Advanced Therapies

Recent Articles

RELATED ARTICLES

  1. Market talk is swirling that WuXi AppTec may be preparing to shed its cell and gene therapy business to limit potential exposure to U.S. biosecurity legislation.
    WuXi AppTec mulls gene unit sale to soften U.S. legal blow
    2359.HK 603259.SHG
  2. WuXi AppTec posts lower profits but avoids more share price pain  
    2359.HK 603259.SHG
  3. Potential U.S. targeting casts shadow over WuXi AppTec family
    2359.HK 603259.SHG
  4. U.S. rethinks timing of biotech crackdown, easing pressure on WuXi family
    2269.HK 2359.HK 2268.HK
  5. GenScript losses shrink on strong growth for cancer cell therapy 
    1548.HK
  6. Increasing losses prompt Zephyrm Bioscience to seek funds through IPO
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva